PHARMACEUTICALS
The pharmaceuticals sector has experienced a period of unprecedented consolidation which has impacted on the demands it makes of its external legal advisers. In January, SmithKline Beecham and Glaxo Wellcome began to arrange a £114bn merger, just weeks before Pfizer and Warner-Lambert announced their £52.1bn merger. This consolidation has led to an increased demand for […]